Harvoni
RxNorm concept 1591944, brand name (bn).
- RxCUI
- 1591944
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1591944 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- ledipasvir 90 MG / sofosbuvir 400 MG [Harvoni] (SBDC, ingredient of)
- ledipasvir / sofosbuvir Oral Tablet [Harvoni] (SBDF, ingredient of)
- Harvoni Oral Product (SBDG, ingredient of)
- Harvoni Pill (SBDG, ingredient of)
- ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet [Harvoni] (SBD, ingredient of)
- ledipasvir 45 MG / sofosbuvir 200 MG [Harvoni] (SBDC, ingredient of)
- ledipasvir 45 MG / sofosbuvir 200 MG Oral Tablet [Harvoni] (SBD, ingredient of)
- ledipasvir / sofosbuvir Oral Pellet [Harvoni] (SBDF, ingredient of)
- Harvoni Pellet Product (SBDG, ingredient of)
- ledipasvir 33.75 MG / sofosbuvir 150 MG [Harvoni] (SBDC, ingredient of)
- ledipasvir 33.75 MG / sofosbuvir 150 MG Oral Pellet [Harvoni] (SBD, ingredient of)
- ledipasvir 45 MG / sofosbuvir 200 MG Oral Pellet [Harvoni] (SBD, ingredient of)
- sofosbuvir (IN, tradename of)
- ledipasvir (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1591944 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1591944 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1591944. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.